Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

NLS Pharmaceutics Ltd. - Common Shares (NQ:NLSP)

1.960 +0.010 (+0.51%)
Streaming Delayed Price Updated: 10:20 AM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NLS Pharmaceutics Ltd. - Common Shares

< Previous 1 2 3 4 5 6 7 8 Next >
Notice of Deficiency with Nasdaq Continued Listing Requirements
Via ACCESSWIRE
NLS Pharmaceutics CEO Issues Letter to Shareholders
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers for Wednesday with a breakdown of all the latest news this morning! 
Via InvestorPlace
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20... 
Via Benzinga
Spotify Layoffs 2023: What to Know About the Latest SPOT Job Cuts
Spotify layoffs are on the way for 17% of the company's workforce as it prepares to reduce headcount to cut operational costs. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Evercore ISI Is Souring on Fisker (FSR) Stock
Fisker stock is falling on Monday after shares of FSR were hit with a downgrade and a lowered price target by Evercore ISI. 
Via InvestorPlace
Why Is Garden Stage (GSIW) Stock Down 38% Today?
Garden Stage stock is dropping on Monday following a rally on Friday when shares of GSIW started trading alongside its IPO. 
Via InvestorPlace
Why Is NLS Pharmaceutics (NLSP) Stock Down 24% Today?
NLS Pharmaceutics stock is falling on Monday after shares of NLSP stock underwent a strong rally with heavy trading on Friday. 
Via InvestorPlace
Why Hawaiian Airlines Shares Are Trading Higher By Over 180%; Here Are 20 Stocks Moving Premarket
Shares of Hawaiian Airlines (NASDAQ: HA) shares rose sharply in pre-market trading after Alaska Air Group, Inc. (NYSE: ALK) announced plans to acquire the company in a 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start of the trading week with a look at the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
NLS Pharmaceutics Announces Exclusive Option Agreement to Develop and Commercialize Next Generation Dual Orexin Agonist Platform of Aexon Labs, Inc.
Via ACCESSWIRE
NLS Pharmaceutics Announces Election of Additional Board Members
Via ACCESSWIRE
NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit: Deep Dive into Narcolepsy and Idiopathic Hypersomnia
Via ACCESSWIRE
Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings. 
Via Benzinga
Why NLS Pharmaceutics (NLSP) Stock Is Down 40% Today
NLS Pharmaceutics AG (NASDAQ: NLSP) shares are trading lower by 40% to $0.30 Thursday morning after the company announced it is seeking strategic alternatives to enhance shareholder value by exploring... 
Via Benzinga
NLS Pharmaceutics Announces Selection of Strategic Partner and Securing a Bridge Loan
Via ACCESSWIRE
Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results. 
Via Benzinga
NLS Pharmaceutics Announces Receipt of Nasdaq Minimum Bid Price Notification
Via ACCESSWIRE
NLS Pharmaceuticals to Reschedule Company Update on Strategic Discussions
Via ACCESSWIRE
NLS Pharmaceutics Announces Company Update on Strategic Partnerships
Via ACCESSWIRE
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares climbed 86.1% to $0.2248 after the company said it is considering strategic alternatives for its non-core operations. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2023
Via Benzinga
Why Okta Shares Are Trading Higher By 11%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another breakdown of the biggest pre-market stock movers as we dive into all of the latest news for Thursday! 
Via InvestorPlace
NLS Pharmaceutics CEO Highlights Progress And Plans For Advancing Rare CNS Disorder Therapies In Shareholder Letter
NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) recently released a comprehensive shareholder letter by its CEO, Alex Zwyer, detailing recent achievements and ongoing endeavors. 
Via Benzinga
NLS Pharmaceutics CEO Issues Letter to Shareholders
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we break down all of the biggest news on Wednesday! 
Via InvestorPlace
Why iMedia Brands Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Prestige Wealth Inc. (NASDAQ: PWM) shares jumped 65.6% to $8.28. Prestige Wealth reported pricing of $5 million initial public offering of 1 million shares of common stock at a price of $5 per... 
Via Benzinga
Why Universal Health Services Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Silicon Motion Technology Corporation (NASDAQ: SIMO) shares climbed 78.9% to $93.40 following a report suggesting China approval of the company's Maxlinear merger. 
Via Benzinga
NLS Pharmaceutics to Proceed with Phase 3 Clinical Program (AMAZE) for Mazindol ER for the Treatment of Narcolepsy Following FDA Review and IRB Approval of the Full Study Protocol
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.